Wet Age Related Macular Degeneration
Links shared publicly online about this topic
Oraya Therapeutics Initiates First Ever Sham-Controlled Study Of Radiation Therapy For Wet AMD
medicalnewstoday.com — “Oraya Therapeutics, Inc., announced that enrollment is now underway for the first ever masked and sham-controlled study to demonstrate the efficacy and safety of radiation therapy for the treatmen” View full resource at medicalnewstoday.com
Most Recently Shared on January 7, 2010 at 4:37 pm By:
Oraya Therapeutics Initiates First Ever Sham-Controlled Study Of Radiation Therapy For Wet AMD Oraya Therapeutics, In.. http://bit.ly/6R9kPY
FDA Grants Priority Review For VEGF Trap-Eye For The Treatment Of Wet Age-Related Macular Degeneration
medicalnewstoday.com — “Regeneron Pharmaceuticals, Inc. (Nasdaq: REGN) announced that the U.S. Food and Drug Administration (FDA) has accepted for review the Company's Biologics License Application (BLA) for VEGF Trap-Ey” View full resource at medicalnewstoday.com
Most Recently Shared on April 19, 2011 at 7:05 am By:
FDA Grants Priority Review For VEGF Trap-Eye For The Treatment Of Wet Age-Related Macular Degeneration http://mnt.to/3TMG #eyehealth
Oraya Therapeutics Completes Enrollment In Pioneering Sham-Controlled Study Of Radiation Therapy For Wet AMD
medicalnewstoday.com — “Oraya Therapeutics, Inc. today announced that it has completed enrollment of its INTREPID clinical trial in Europe. The study is the first sham-controlled, double-masked trial to evaluate the effe” View full resource at medicalnewstoday.com
Most Recently Shared on May 18, 2011 at 3:05 pm By:
Oraya Therapeutics Completes Enrollment In Pioneering Sham-Controlled Study Of Radiation Therapy For Wet AMD http://mnt.to/3W3n #eyehealth
New wet AMD treatment a step closer - Ophthalmology Times Europe
oteurope.com — “The CABERNET (CNV Secondary to AMD Treated with Beta RadiatioN Epiretinal Therapy) clinical trial is pivotal to establishing the safety and effectiveness of a beta radiation based focal epimacular brachytherapy device. Its development in bringing a paradigm shift in the way retina specialists treat wet AMD patients moved a step closer as Neovista Inc. secured more than $18 million in its Series D private venture funding round.” View full resource at oteurope.com
Most Recently Shared on March 26, 2009 at 11:30 am By:
Ophthalmology Times Ophthalmology and Health Magazine
CABERNET trial of radiation treatment for wet AMD given boost. http://ow.ly/1s9z
NeoVista Radiation Theraphy for Wet AMD Utilized in Germany
eyedocnews.com — “Epi-retinal application of strontium 90 radiation for the treatment of wet AMD utilized in Germany” View full resource at eyedocnews.com
Most Recently Shared on February 2, 2011 at 9:55 am By:
Dr. Ari Weitzner Doctor, Ophthalmologist, and Physician
Discuss: NeoVista Announces First Commercial Utilization of Epimacular Brachytherapy in Germany to Treat Wet AMD... http://bit.ly/hWKobR
Biologics license applied for wet AMD treatment - Ophthalmology Times Europe
oteurope.com — “A Biologics License Application (BLA) for VEGF Trap-Eye treatment of neovascular age-related AMD has been submitted to the US Food and Drug Administration (FDA) by Regeneron Pharmaceuticals.” View full resource at oteurope.com
Most Recently Shared on March 11, 2011 at 12:27 pm By:
Ophthalmology Times Ophthalmology and Health Magazine
News Update: Biologics license applied for wet AMD treatment http://ow.ly/1bIvnJ
NeoVista receives CE mark for wet AMD therapy system
osnsupersite.com — “FREMONT, Calif. — NeoVista has received approval to apply the CE mark to its VIDION Anti-Neovascular Therapy System for treating wet age-related” View full resource at osnsupersite.com
Most Recently Shared on August 5, 2009 at 3:37 pm By:
NeoVista receives CE mark for wet AMD therapy system: http://ow.ly/ja4p
Avastin vs. Lucentis in Wet Age-Related Macular Degeneration By: Wendy Bedale - The LASIK Blog
lasikblog.typepad.com — “I have blogged several times about the Avastin vs. Lucentis controversy. Irv Aron , a retired consultant in the Medical Laser industry, blogs regulary about this topic as well in Irv Arons' Journal. Last week, he posted a paper written...” View full resource at lasikblog.typepad.com
Most Recently Shared on July 6, 2010 at 4:38 pm By:
TheLASIKDoc Ophthalmologist, Physician, Doctor, and Surgeon
Avastin vs. Lucentis in Wet Age-Related Macular Degeneration By: Wendy Bedale http://bit.ly/cUOyCy
Combination therapy reduces re-treatment burden in wet AMD patients
osnsupersite.com — “VANCOUVER, British Columbia — Combination therapies generated greater visual acuity gains with fewer reinjections compared with monotherapy” View full resource at osnsupersite.com
Most Recently Shared on June 23, 2010 at 3:48 pm By:
Combination therapy reduces re-treatment burden in wet AMD patients: http://ht.ly/22hlo
Study describes long-term effects of PDT in wet AMD
osnsupersite.com — “Photodynamic therapy is safe for long-term treatment of exudative age-related macular degeneration, but it is not definitive because it does not stop” View full resource at osnsupersite.com
Most Recently Shared on June 18, 2009 at 3:35 pm By:
Study describes long-term effects of PDT in wet AMD: http://ow.ly/eOZb
Report highlights need to treat wet AMD as chronic disease
osnsupersite.com — “AMD Alliance International issued a global call to action in a webcast Monday urging government and health care officials to address the need fo” View full resource at osnsupersite.com
Most Recently Shared on April 19, 2011 at 3:46 pm By:
Report highlights need to treat wet #AMD as chronic disease: http://ht.ly/4Dsd9
Questionnaire proves reliable in assessing visual function in patients with wet AMD
osnsupersite.com — “A questionnaire was found to be a sensitive, dynamic measure of visual function in patients undergoing pharmacologic treatment for wet age-related mac” View full resource at osnsupersite.com
Most Recently Shared on August 24, 2009 at 2:45 pm By:
Top Story: Questionnaire proves reliable in assessing visual function in patients with wet #AMD http://ow.ly/l6T4
Oraya Therapeutics receives CE mark for radiation therapy system for wet AMD
osnsupersite.com — “NEWARK, Calif. " Oraya Therapeutics has received approval to apply a CE mark to its IRay stereotactic radiotherapy system for treating wet age-related” View full resource at osnsupersite.com
Most Recently Shared on April 8, 2010 at 3:39 pm By:
Oraya Therapeutics receives CE mark for #radiation therapy system for wet AMD: http://ow.ly/1w5ex
Avastin and Lucentis Equally Effective in Stopping Wet AMD
eyedocnews.com — “Study finds patients receiving either drug showed improvement in vision” View full resource at eyedocnews.com
Most Recently Shared on April 29, 2011 at 10:26 am By:
Dr. Ari Weitzner Doctor, Ophthalmologist, and Physician
Discuss: CATT Study Finds No Difference Between Avastin and Lucentis in Stopping Progression of Wet Macular Dege... http://bit.ly/jP8g1o
FDA pushes back action date for priority review of wet AMD treatment
osnsupersite.com — “TARRYTOWN, N.Y. - The U.S. Food and Drug Administration has extended its estimated completion date for the priority review of Regeneron's Eylea Biolog” View full resource at osnsupersite.com
Most Recently Shared on August 18, 2011 at 7:00 pm By:
#FDA pushes back action date for priority review of wet #AMD treatment http://ht.ly/66HG9
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Related WisdomCards
Related Health Centers
Featuring the top 3 experts for this topic
-
medical_tweets
-
MNT Eye Health
The latest eye health news published daily. Articles from research centers, universities and prestigious journals.
-
MNT Eye Health
The latest eye health news published daily. Articles from research centers, universities and prestigious journals.
Advertisement
